Ngt3vc is a Nazareth-based venture capital firm investing in early-stage Israeli medical device and life sciences companies. The firm is structured as an impact fund and focuses on health-related innovation across medical technologies, biotechnology, HealthTech and pharmaceuticals, with access to non-dilutive support through Israel’s Innovation Authority and local universities, hospitals, research institutions and multinational corporations.